Summary
Three Canadian cannabis companies have landed the first German medical cannabis cultivation licenses. Each of Aurora Cannabis (ACB), Aphria (APHA), and Wayland Group (MRRCF) were awarded medical cannabis cultivation licenses in Germany on April 4th.
These licenses are for relatively low cultivation figures but could help open the door for these three groups to begin producing and selling cannabis in the developing, but potentially enormous, German cannabis market. Some analysts suggest the German medical cannabis market will be worth up to U$2.7 billion by 2023.